GSK en las noticias
Uniendo ciencia tecnología talento
Tamtam encontró 20 artículos recientes sobre GSK.
- GSK (LSE:GSK) Adds A New Hepatology Candidate, Is The 18% Undervaluation Case Intact?
- GSK plc : Berenberg remains its Buy rating
- GSK: The Gas Pedal Is Finally Down (NYSE:GSK)
- Can HUTCHMED (LSE:HCM) turn its FTSE 100 partner GSK into clinical momentum after dosing a first patient?
- REG - GSK PLC - Admission to Trading
- 19,352 GSK (GSK) shares join London trading under its Share Save Plan 2022.
- GSK-owned ViiV succeeds in late-stage trial for HIV therapy
- Why Is GSK (LSE:GSK) Stock Back In Focus This Week After The Nuvalent Agreement?
- GSK Announces Admission of 19,352 Shares Under Share Save Plan to London Stock Exchange
- Avalere Health names GSK alum Wendy Jory, Ph.D. as senior VP, market access
- AN2 Therapeutics Secures Extended Gates Foundation Funding For GSK Tuberculosis Collaboration
- GSK stock reports Q2 sales growth despite profit hit
- Can FTSE 100 Drugmaker (LSE:GSK) Turn Its Nuvalent Acquisition Into A Fresh Growth Engine After This Week's Deal News?
- GSK’s Regional President Mike Crichton on leading winning teams from Singapore
- GSK agrees to acquire myeloma therapy. GSK stock costs EUR 20.83
- GSK agrees to acquire ChImagen therapy: what it means for GSK stock at $750 million
- GSK | 10/2/26
- GSK Sports and Social Club vows to fight closure
- How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate?
- GSK (LSE:GSK) Gets Extended Gates Funding For Tuberculosis Drug Research
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como GSK?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares